Today: November 18, 2018, 9:36 am
  
Business

Prothena to Participate in the 36th Annual J.P. Morgan Healthcare Conference

PR-Inside.com: 2018-01-03 22:06:02

DUBLIN, Ireland, Jan. 3, 2018 - Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in the neuroscience and orphan categories, today announced that members of its senior management team will present and participate in the 36th Annual J.P. Morgan Healthcare Conference on January 10th at 8:30 AM PT in San Francisco, CA. 

A live webcast of the company presentation can be accessed through the Investors section of the Company's website at www.prothena.com. Following the live presentation, a replay of the webcast will be available on the Company's website for at least 90 days following the presentation date.

About Prothena

Prothena Corporation plc is a global, late-stage clinical biotechnology company establishing fully integrated research, development and commercial capabilities and focused on advancing new therapies in the neuroscience and orphan categories. Fueled by its deep scientific understanding built over decades of research in protein misfolding, Prothena seeks to fundamentally change the course of grave or currently untreatable diseases associated with this biology. Prothena's pipeline of antibody therapeutic candidates targets a number of indications including AL amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002/RG7935) and ATTR amyloidosis (PRX004). The Company continues discovery of additional novel therapeutic candidates where its deep scientific understanding of disease pathology can be leveraged. For more information, please visit the Company's website at www.prothena.com.

Media & Investor Contact:

Ellen Rose, Head of Communications

650-922-2405, ellen.rose@prothena.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Prothena Corporation plc via Globenewswire




# 403 Words
Related Articles
 
More From Business
The Greatest Biosoft Gels From Cancer by [..]
17th November 2018 - Purtier Placenta provides interesting products for everyone. If you are ready to start your experience with [..]
Get Flavors for Your Electronic Cigarette from [..]
17th November 2018 - Vapeshack provides great services for those who are ready to pay for comfort. Are you a [..]
The Very Efficient Instagram Boosting Services from [..]
17th November 2018 - Social Result is a very user friendly and informative platform, for those who are ready to [..]
Smart Options Helps Navigate Through Cryptocurrency Signals
16 November 2018 – Smart Options is offering to boost your crypto knowledge with the most trustworthy cryptocurrency signals to [..]
Get the Powerful Hints to Start Your [..]
16 November 2018 – The Price Organization LLC present to the attention of internet users Wealthy Affiliate Review, which is [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.